SiBone reports Q3 loss narrowing and reaffirmed FY26 revenue outlook

SiBone (SIBN) announced third‑quarter results showing a narrower net loss and a 14.5% rise in revenue to $55.7 million. Management highlighted strong procedure volume growth, especially in the U.S., and reaffirmed its full‑year 2026 revenue guidance of $231 million‑$233 million. The company also noted cash and short‑term investments of about $146 million and a modest operating‑expense growth outlook.

The reaffirmed FY26 revenue range gives investors clarity on expected top‑line growth, while the improved cash position and lower loss suggest better near‑term financial health. The company also lowered its operating‑expense growth target to roughly 10.5%, which may support margin expansion.

  • 1Net loss narrowed to $3.62 million, or $0.08 per diluted share, from $4.60 million a year earlier.
  • 2Worldwide revenue increased 14.5% to $55.70 million.
  • 3U.S. revenue grew 13.9% to $52.8 million.
  • 4International revenue rose 27% to $2.9 million.
  • 5Cash and cash equivalents with short‑term investments totaled $146.26 million as of September 30, 2026.
  • 6Full‑year 2026 revenue guidance reaffirmed at $231 million‑$233 million.

Sources